| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000038104 |
| Receipt No. | R000042859 |
| Scientific Title | A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery |
| Date of disclosure of the study information | 2019/09/26 |
| Last modified on | 2022/04/06 (Ver. 4) |
| Basic information | ||
| Public title | A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery | |
| Acronym | A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery | |
| Scientific Title | A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery | |
| Scientific Title:Acronym | A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery | |
| Region |
|
|
| Condition | |||
| Condition | Patients who received either laparoscopic gastrectomy or laparoscopic colectomy. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The purpose is to examine whether a single rectus sheath block is not inferior to continuous epidural anesthesia as postoperative analgesia for patients who have undergone either laparoscopic gastrectomy or laparoscopic colectomy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Pain scale (Numerical Rating Scale) when coughing 24 hours after surgery |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Epidural anesthesia group
Before inducing anesthesia, perform catheter placement at the 9th to 11th thoracic vertebrae levels. Administer 0.375% ropivacaine epidurally at the start of wound closure. Patient-controlled epidural analgesia (PCEA) starts at the end of surgery. The drug solution is 0.2% Anapain and 3 mcg / mL fentanyl. Settings: Dosing rate 4 mL / h, bolus administration 2 mL, dosing interval 15 minutes or more, maximum one-time bolus administration 4 times. |
||
| Interventions/Control_2 | Rectus sheath block group
After the introduction of anesthesia, before the start of surgery. At the umbilical level, 15 mL of 0.375% Anapane is administered under echo guide. |
||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients scheduled to undergo laparoscopic gastrectomy or laparoscopic colorectal resection of 6 cm or less where the wound is continuous with the umbilicus in addition to the port hole.
Age: 20 years old and younger than 80 years old at the time of obtaining consent ASA-PS (American Society of Anesthesiologists physical status): 1-3 Patients who have received sufficient explanation for participation in this study, and who have fully understood and agreed to the document by their own will. |
|||
| Key exclusion criteria | Antiplatelet / anticoagulant therapy
There is a decrease in platelet count (80,000 <mcL), blood coagulation ability abnormality (aPTT> control value + 10 seconds or PT (%) <50%) History of spine surgery There is an allergy to the anesthetic used Weight less than 40 kg BMI> 30 kg / m2 Patients whose pain is difficult to evaluate (psycho-neuropathy, dementia, restlessness, etc.) Use regular painkillers Liver dysfunction (AST or ALT> 100 IU / L) Renal dysfunction (eGFR <50 mL / min / 1.73m2) |
|||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery | ||||||
| Zip code | 305-8576 | ||||||
| Address | 2-1-1 Amakubo, Tsukuba, Ibaraki | ||||||
| TEL | 029-853-3221 | ||||||
| y.owada@md.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery | ||||||
| Zip code | 305-8575 | ||||||
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki | ||||||
| TEL | 029-853-3221 | ||||||
| Homepage URL | |||||||
| y.owada@md.tsukuba.ac.jp | |||||||
| Sponsor | |
| Institute | University of Tsukuba |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tsukuba Clinical Research & Development Organization |
| Address | 2-1-1 Amakubo, Tsukuba, Ibaraki |
| Tel | 029-853-3914 |
| t-credo.adm@un.tsukuba.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 80 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000042859 |